Korea’s Hanmi, U.S. Spectrum To Co-Develop Biobetter Of Amgen’s GCSF Neulasta For Neutropenia
This article was originally published in PharmAsia News
Executive Summary
Hanmi Pharmaceutical inks another deal with a foreign pharma company as it focuses on business opportunities outside Korea.